Cargando…

Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists

Neurokinin 3 receptor (NK3R) is a tachykinin receptor essential for the hypothalamic-pituitary-gonadal axis. The endogenous peptide agonist neurokinin B (NKB) preferentially activates NK3R, while substance P (SP) binds preferentially to NK1R. In addition, the SP analogue senktide more potently activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wenjing, Yang, Fan, Zhang, Huanhuan, Yuan, Qingning, Ling, Shenglong, Wang, Yuanxia, Lv, Pei, Li, Zelin, Luo, Yifan, Liu, Dongsheng, Yin, Wanchao, Shi, Pan, Xu, H. Eric, Tian, Changlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313662/
https://www.ncbi.nlm.nih.gov/pubmed/37391393
http://dx.doi.org/10.1038/s41421-023-00564-w
_version_ 1785067164370206720
author Sun, Wenjing
Yang, Fan
Zhang, Huanhuan
Yuan, Qingning
Ling, Shenglong
Wang, Yuanxia
Lv, Pei
Li, Zelin
Luo, Yifan
Liu, Dongsheng
Yin, Wanchao
Shi, Pan
Xu, H. Eric
Tian, Changlin
author_facet Sun, Wenjing
Yang, Fan
Zhang, Huanhuan
Yuan, Qingning
Ling, Shenglong
Wang, Yuanxia
Lv, Pei
Li, Zelin
Luo, Yifan
Liu, Dongsheng
Yin, Wanchao
Shi, Pan
Xu, H. Eric
Tian, Changlin
author_sort Sun, Wenjing
collection PubMed
description Neurokinin 3 receptor (NK3R) is a tachykinin receptor essential for the hypothalamic-pituitary-gonadal axis. The endogenous peptide agonist neurokinin B (NKB) preferentially activates NK3R, while substance P (SP) binds preferentially to NK1R. In addition, the SP analogue senktide more potently activates NK3R than NKB and SP. However, the mechanisms of preferential binding of peptide and NK3R activation remain elusive. Herein, we determined the cryogenic electron microscopy (cryo-EM) structures of the NK3R–G(q) complex bound to NKB, SP and senktide. The three NK3R–G(q)/peptide complexes utilize a class of noncanonical receptor activation mechanisms. Combining the structural analysis and functional assay illustrated that the consensus C-termini of the three peptide agonists share a conserved binding mode to NK3R, while the divergent N-termini of the peptides confer the preferential binding of the agonist to NK3R. In addition, the specific interactions between the N-terminus of senktide and the N-terminus and extracellular loops (ECL2 and ECL3) of NK3R lead to the improved activation displayed by senktide compared to SP and NKB. These findings pave the way to understand tachykinin receptor subtype selectivity and provide ideas to rationally develop drugs targeting NK3R.
format Online
Article
Text
id pubmed-10313662
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-103136622023-07-02 Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists Sun, Wenjing Yang, Fan Zhang, Huanhuan Yuan, Qingning Ling, Shenglong Wang, Yuanxia Lv, Pei Li, Zelin Luo, Yifan Liu, Dongsheng Yin, Wanchao Shi, Pan Xu, H. Eric Tian, Changlin Cell Discov Article Neurokinin 3 receptor (NK3R) is a tachykinin receptor essential for the hypothalamic-pituitary-gonadal axis. The endogenous peptide agonist neurokinin B (NKB) preferentially activates NK3R, while substance P (SP) binds preferentially to NK1R. In addition, the SP analogue senktide more potently activates NK3R than NKB and SP. However, the mechanisms of preferential binding of peptide and NK3R activation remain elusive. Herein, we determined the cryogenic electron microscopy (cryo-EM) structures of the NK3R–G(q) complex bound to NKB, SP and senktide. The three NK3R–G(q)/peptide complexes utilize a class of noncanonical receptor activation mechanisms. Combining the structural analysis and functional assay illustrated that the consensus C-termini of the three peptide agonists share a conserved binding mode to NK3R, while the divergent N-termini of the peptides confer the preferential binding of the agonist to NK3R. In addition, the specific interactions between the N-terminus of senktide and the N-terminus and extracellular loops (ECL2 and ECL3) of NK3R lead to the improved activation displayed by senktide compared to SP and NKB. These findings pave the way to understand tachykinin receptor subtype selectivity and provide ideas to rationally develop drugs targeting NK3R. Springer Nature Singapore 2023-06-30 /pmc/articles/PMC10313662/ /pubmed/37391393 http://dx.doi.org/10.1038/s41421-023-00564-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Sun, Wenjing
Yang, Fan
Zhang, Huanhuan
Yuan, Qingning
Ling, Shenglong
Wang, Yuanxia
Lv, Pei
Li, Zelin
Luo, Yifan
Liu, Dongsheng
Yin, Wanchao
Shi, Pan
Xu, H. Eric
Tian, Changlin
Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
title Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
title_full Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
title_fullStr Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
title_full_unstemmed Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
title_short Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
title_sort structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313662/
https://www.ncbi.nlm.nih.gov/pubmed/37391393
http://dx.doi.org/10.1038/s41421-023-00564-w
work_keys_str_mv AT sunwenjing structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT yangfan structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT zhanghuanhuan structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT yuanqingning structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT lingshenglong structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT wangyuanxia structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT lvpei structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT lizelin structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT luoyifan structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT liudongsheng structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT yinwanchao structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT shipan structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT xuheric structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists
AT tianchanglin structuralinsightsintoneurokinin3receptoractivationbyendogenousandanaloguepeptideagonists